, Denver; Christine Knight, Jennifer Conn, Peter England, Susan Hiscock, Jeremy Oats, and Peter Wein from the University of Melbourne, Melbourne, Australia; Torun Clausen and Bjorg Lorentzen from the Oslo University Hospital, Oslo, Norway; and Azar Dashti, Lori Doyle, and Kenneth W. Wilson from the University of Oklahoma, Oklahoma City. The authors also acknowledge the scientific contributions from the following personnel:DIABETES CARE, VOLUME 36, JULY 2013Inflammation and preeclampsia in T1DM pregnancyAlison J. Nankervis in the Royal Women’s Hospital, Australia; Hanne Scholz and Tore Henriksen from the University of Oslo; Kathryn M. Menard from the University of North Carolina; Paul Smith in the Oklahoma Healthcare Study Foundation; Yongxin Yu in the University of Oklahoma; and John R. Stanley in the Mercy Wellness Center, Oklahoma City, Oklahoma. References 1. Manten GT, Sikkema MJ, Voorbij HA, Visser GH, Bruinse HW, Franx A. Risk variables for cardiovascular illness in ladies using a history of pregnancy difficult by preeclampsia or intrauterine development restriction. Hypertens Pregnancy 2007;26: 39?0 two. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499?06 3. de Jonge LL, Steegers EA, Ernst GD, et al. C-reactive protein levels, blood stress along with the risks of gestational hypertensive complications: the Generation R Study. J Hypertens 2011;29: 2413?421 4. Forest JC, Charland M, Mass?J, et al. Candidate biochemical markers for screening of pre-eclampsia in early pregnancy.1073371-77-3 Formula Clin Chem Lab Med 2012; 50:973?84 five. Ertas IE, Kahyaoglu S, Yilmaz B, et al. Association of maternal serum higher sensitive C-reactive protein level with body mass index and severity of pre-eclampsia at third trimester. J Obstet Gynaecol Res 2010;36:970?77 6. Molvarec A, Szarka A, Walentin S, et al. Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic variables in regular pregnancy and preeclampsia. Reprod Biol Endocrinol 2011;9:124 7. Cemgil Arikan D, Aral M, Coskun A, Ozer A. Plasma IL-4, IL-8, IL-12, interferon-g and CRP levels in pregnant girls with preeclampsia, and their relation with severity of disease and fetal birth weight. J Matern Fetal Neonatal Med 2012;25: 1569?573 8.[Acr-Mes]+(ClO4)- Chemscene Montagnana M, Lippi G, Albiero A, Salvagno GL, Franchi M, Guidi GC.PMID:24101108 Serum pro-inflammatory cytokines in physiological and pre-eclamptic pregnancies. Gynecol Endocrinol 2008;24: 113?16 9. Jonsson Y, Rub M, Matthiesen L, et al. Cytokine mapping of sera from women with preeclampsia and regular pregnancies. J Reprod Immunol 2006;70: 83?1 10. Carty DM, Anderson LA, Freeman DJ, et al. Early pregnancy soluble E-selectin concentrations and threat of preeclampsia. J Hypertens 2012;30:954?2060 DIABETES CARE, VOLUME 36, JULY11. Clausen T, Djurovic S, Brosstad FR, Berg K, Henriksen T. Altered circulating levels of adhesion molecules at 18 weeks’ gestation amongst women with eventual preeclampsia: indicators of disturbed placentation in absence of evidence of endothelial dysfunction? Am J Obstet Gynecol 2000;182:321?325 12. Kronborg CS, Gjedsted J, Vittinghus E, Hansen TK, Allen J, Knudsen UB. Longitudinal measurement of cytokines in pre-eclamptic and normotensive pregnancies. Acta Obstet Gynecol Scand 2011; 90:791?96 13. Clausen P, Ekbom P, Damm P, et al. Indicators of maternal vascular dysfunction precede preeclampsia in females with sort 1 diabetes. J Diabetes Complications 2007;.